Based on the role of adiponectin in the abovementioned signaling pathways, the short peptide ADP355 based on adiponectin can exert antiproliferative effects in breast cancer cells through the STAT3 and ERK1/2 signaling pathways (39, 90). Here, ADIPOQ is linked to breast carcinoma.